Journal of Psychoactive Drugs 2010: Vol 42 Index

2010·1.4 MB·English

Index
Volume 42 (1-4), 2010
AUTHORS
Amen, Daniel G. 42 (2): 153-160. Dillon, Frank 42 (4): 457-466.
Anderson, Beth M. 42 (1): 19-30; 42 (4): 413-424. Ding, Y.Y. 42 (1): 1-9.
Anderson, Ilene B. 42 (3): 385-392. DiNitto, Diana M. 42 (3): 393-399.
Annon, Jeffrey J. SARC 6: 269-276. Distiller, Greg 42 (4): 467-476.
Arayasirikul, S. 42 (1): 1-9. Dunlap, Eloise 42 (3):327-337.
Awegu, Ezechukwu 42 (3): 339-346. DuPont, Robert L. 42 (2): 127-132.
Banerjee, Kakoli SARC 6: 295-302. Edokpolo, Osamede 42 (1): 31-36.
Barger, James SARC 6: 269-276. Elifson, Kirk W. 42 (1): 63-71; 42 (4): 447-456.
Bell, Holly 42 (3): 393-399. Falck, Russel 42 (4): 435-445.
Bellows, Anne SARC 6: 249-259. Feeney, Kevin 42 (4): 499-506.
Benoit, Ellen 42 (3):327-337. Feigelman, William 42 (3): 353-361.
Berrino, Liberato 42 (4): 507-512. Flisher, Alan J. 42 (1): 37-47; 42 (4): 467-476.
Biglete, Shannon A. 42 (3): 385-392. Ford, Lucy K. SARC 6: 303-314.
Block, Robert I. 42 (1): 19-30; 42 (4): 413-424. Fortuna, Jeffrey L. 42 (2): 147-151.
Boettiger, Charlotte A. 42 (2): 177-192. Francis, Elie M. 42 (2): 193-198.
Bohman, Thomas 42 (3): 393-399. Freese, Thomas SARC 6: 207-210.
Bond, Jason 42 (1): 49-62; 425-433. Fu, C. 42 (1): 1-9.
Booth, Brenda M. 42 (3): 377-383; 42 (4): 435-445. Galloway, Gantt P. 42 (1): 49-62; 42 (4): 425-433.
Brecht, Mary-Lynn SARC 6: 211-214. Ganapati, Emel N. 42 (4): 457-466.
Brown, Sandra A. 42 (3): 401-412. Garcia-Rodriguez, Olaya 42 (3): 347-352.
Busch-Armendariz, Noél Bridget 42 (3): 393-399. Garfein, Richard S. L. 42 (1): 11-18.
Campbell, Ann 42 (1): 31-36. Garland, Eric L. 42 (2): 177-192.
Capuano, Annalisa 42 (4): 507-512. Garner, Robert SARC 6: 295-302.
Carlini, Marina 42 (1): 89-95. Gaylord, Susan A. 42 (2): 177-192.
Carlson, Robert G. 42 (3): 377-383; 42 (4): 435-445. Glass, Joseph E. 42 (3): 315-325.
Chalk, Mady SARC 6: 211-214. Gold, Mark S. 42 (2): 133-145.
Chen, Gila 42 (3): 363-375. Golia, Francesca 42 (1): 89-95.
Cheng, W. Susan 42 (1): 11-18. Golub, Andrew 42 (3):327-337.
Chermack, Stephen T. 42 (3): 315-325. G6émez, Francisco José Santonja 42 (3): 347-352.
Ching, Gene 42 (4): 513-514. Gonzales, Rachel SARC 6: 211-214, 261-268, 269-276.
Crévecoeur-MacPhail, Desirée SARC 6: 211-214, 249-259, Gonzales-Nolas, Cheryl 42 (2): 193-198.
269-276. Gorman, Bernard S. 42 (3): 353361.
Cunningham, Michael SARC 6: 211-214. Greenfield, Thomas K. 42 (1): 49-62.
Daniulaityte, Raminta 42 (4): 435-445. Guydish, Joseph SARC 6: 215-226.
Dannaway, Frederick R. 42 (4): 485-497. Hague, Diane 42 (1): 73-81.
Davidson, Leigh Dickerson 42 (2): 121-126. Harris, William W. SARC 6: 277-285.
Davoudi, Mehrnaz SARC 6: 239-248. He, N. 42 (1): 1-9.
De La Rosa, Mario R. 42 (4): 457-466. Herbeck, Diane M. SARC 6: 261-268.
Dell’ Osso, Liliana 42 (1): 89-95. Hofstedt, Thomas SARC 6: 287-293.
Deltito, Joseph 42 (1): 89-95. Howard, Matthew O. 42 (2): 177-192.
De Novellis, Vito 42 (4): 507-512. Huang, Z.J. 42 (1): 1-9.
Diep, Nancy SARC 6: 269-276. Iigen, Mark A. 42 (3): 315-325.
Journal of Psychoactive Drugs Volume 42 (4), December 2010
Volume 42 (2010)
James, Philip 42 (1): 31-36. Roy, Ken 42 (2): 115-120.
Jessup, Martha SARC 6: 215-226. Rutkowski, Beth SARC 6: 207-210, 227-238, 249-259.
Kaplan, Stephen SARC 6: 287-293. Ryan, Jan SARC 6: 277-285.
Kearns, Caitriona 42 (1): 31-36. Saban, Amina 42 (1): 37-47; 42 (4): 467-476.
Kemp, Jack SARC 6: 211-214. Sanchez-Hervas, Emilio 42 (3): 347-352.
Kim, Sunny 42 (4): 457-466. Saniotis, Arthur 42 (4): 477-484.
King, Bryn SARC 6: 287-293. Scafuro, Maria Antonietta 42 (4): 507-512.
Klein, Hugh 42 (1): 63-71; 42 (4): 447-456. Schweinsburg, Alecia D. 42 (3): 401-412.
Kobeissy, Firas H. 42 (2): 133-145. Schweinsburg, Brian C. 42 (3): 401-412.
Korcha, Rachael 42 (1): 49-62; 42 (4): 425-433. Secades-Villa, Roberto 42 (3): 347-352.
Kovas, Anne E. SARC 6: 227-238. Semple, Shirley J. 42 (1): 11-18.
Krippner, Stanley 42 (4): 515-516. Sexton, Rocky L. 42 (3): 377-383.
Kropp, Frankie 42 (1): 73-81. Smith, David E. 42 (2): 97-98, 121-126, 161-175
Lai, Emily P. 42 (3): 385-392. 201.
Lang, Ariel J. 42 (1): 83-87. Smyth, Bobby P. 42 (1): 31-36.
Lee, Diana Y. 42 (3): 385-392. Somoza, Eugene 42 (1): 73-81.
Lee, Dorothy R. 42 (2): 99-114, 121-126. Stanford, Mark SARC 6: 295-302.
Lee, Paul 42 (2): 99-114. Stefania, Canoniero 42 (1): 89-95.
Lee, Philip R. 42 (2): 99-114 Stella, Luigi 42 (4): 507-512.
Leukefeld, Carl G. 42 (3): 377-383; 42 (4): 435-445. Sterk, Claire E. 42 (1): 63-71; 42 (4): 447-456.
Lewis, Daniel 42 (1): 73-81. Strathdee, Steffanie A. 42 (1): 11-18.
Liu, Yijun 42 (2): 133-145. Sugita, Wayne SARC 6: 269-276.
Magura, Stephen 42 (3): 339-346. Tajima, Barbara SARC 6: 215-226.
Maione, Sabatino4 2 (4): 507-512. Tapert, Susan F. 42 (1): 83-87; 42 (3): 401-412.
Manser, Sarah Turcotte SARC 6: 215-226. Torrecer, Gilsky I. 42 (3): 385-392.
Maremmani, Angelo G.I. 42 (1): 89-95. Urada, Darren SARC 6: 211-214.
Maremmani, Icro 42 (1): 89-95. Viernes, Jr., John SARC 6: 269-276.
Markowitz, Joseph D. 42 (2): 193-198. Vitelli, Maria Redenta 42 (4): 507-512.
McQueeny, Tim 42 (3): 401-412. von Deneen, Karen M. 42 (2): 133-145.
Medina, Krista Lisdahl 42 (3): 401-412. Wang, Jichuan 42 (4): 435-445.
Miller, Michael 42 (2): 115-120. Wesson, Donald 42 (2): 161-175.
Murray, Regan L. 42 (3): 315-325. Wilkins, Kendall C. 42 (1): 83-87.
Myers, Ana Ceci SARC 6: 249-259, 269-276. Winhusen, Theresa 42 (1): 73-81.
Najavits, Lisa M. 42 (1): 83-87. Winters, Jamie J. 42 (3): 315-325.
Niyonsenga, Theophile 42 (4): 457-466. Wong, Frank Y. 42 (1): 1-9.
Norman, Sonya B. 42 (1): 83-87. Yanez, Elena Martin 42 (3): 347-352.
Nyi, Pearl P. 42 (3): 385-392. Young, D. 42 (1): 1-9.
O’Conor, C. 42 (1): 1-9. Zarate, Patrick SARC 6: 303-314.
O'Leary, Daniel S. 42 (1): 19-30; 42 (4): 413-424. Zians, James K. 42 (1): 11-18.
Oliva, Patrizia 42 (4): 507-512. Zito, Renée SARC 6: 205-206.
Pacini, Matteo 42 (1): 89-95.
Palazzo, Enza4 2 (4): 507-512.
Patterson, Thomas L. 42 (1): 11-18.
Pearlson, Godfrey D. 42 (1): 19-30; 42 (4): 413-424. ADOLESCENTS
Perron, Brian E. 42 (3): 315-325. Association between psychopathology and substance use
Polcin, Douglas L. 42 (1): 49-62; 42 (4): 425-433. among school-going adolescents in Cape Town, South
Ransom, Loretta SARC 6: 249-259, 269-276. Africa. Saban, A.; Flisher, A.J. & Distiller, G. 42 (4): 467-
Rawson, Richard SARC 6: 207-210, 211-214, 239-248, 476.
249-259, 261-268, 269-276. The association between psychopathology and substance
Rieckmann, Traci SARC 6: 227-238. use in young people: A review of the literature. Saban, A.
Rizzo, Matthew 42 (1): 19-30; 42 (4): 413-424. & Flisher, A.J. 42 (1): 37-47.
Rojas, Patria 42 (4): 457-466. Gender differences in psychiatric symptomatology in ado-
Romaguera, Francisco Zacarés 42 (3): 347-352. lescents attending a community drug and alcohol treatment
Rosenblum, Andrew 42 (3): 339-346. program. Edokpolo, O.; James, P.; Kearns, C.; Campbell,
Rossi, Francesco4 2 (4): 507-512. A. & Smyth, B.P. 42 (1): 31-36.
Journal of Psychoactive Drugs Volume 42 (4), December 2010
Volume 42 (2010)
Prospective predictors of premature death: Evidence from DRUG POLICY
the National Longitudinal Study of Adolescent Health. 2010: U.S. drug and alcohol policy, looking back and moving
Feigelman, W. & Gorman, B.S. 42 (3): 353-361. forward. Lee, P.R.; Lee, D.R. & Lee, P. 42 (2): 99-114.
Editors’ introduction: Addiction and related disorders.
AFRICAN-AMERICANS Smith, D.E. 42 (2): 97-98.
Drug use and conflict in inner-city African-American rela- Editor’s introduction: Improving the addiction treatment system
tionships in the 2000s. Golub, A.; Dunlap, E. & Benoit, E. in California through the use of data and evidence-based practices
42 (3): 327-337. —California Substance Abuse Research Consortium (SARC) Meet-
ings, 2009. Rutkowski, B.; Rawson, R. & Freese, T. SARC
ALCOHOL 6: 207-210.
Correlates of heavy drinking behaviors of Latino mothers Editor’s note: The evolution of addiction medicine and its
and their adult daughters. Niyonsenga, T.; Rojas, P.; Dillon, San Francisco roots. Smith, D.E. 42 (2): 199-201.
F.; Kim, S.; Ganapati, E.N. & De La Rosa, M. R. 42 (4): Health care equality and parity for treatment of addictive disease.
457-466. Smith, D.E.; Lee, D.R. & Davidson, L.D. 42 (2): 121-126.
Mindfulness training modifies cognitive, affective, and Improving the accountability of California’s Public sub-
physiological mechanisms implicated in alcohol depen- stance abuse treatment system through the implementation
dence: Results of a randomized controlled pilot trial. of performance model. Rawson, R.A.; Gonzales, R.; Créve-
Garland, E.L.; Gaylord, S.A.; Boettiger, C.A. & Howard, coeur-MacPhail, D.; Urada, D.; Brecht, M.-L.; Chalk, M.;
M.O. 42 (2): 177-192. Kemp, J. & Cunningham, M. SARC 6: 211-214.
Sweet preference, sugar addiction and the familial history Parity and the medicalization of addiction treatment. Roy,
of alcohol dependence: Shared neural pathways and genes. K. & Miller, M. 42 (2): 115-120.
Fortuna, J.L. 42 (2): 147-151. Substance Abuse Research Consortium (SARC) introduc-
tion: Moving forward to improve addiction treatment in
BOOK REVIEW California. Zito, R. SARC 6: 205-206.
The Acid Diaries: A Psychonaut’s Guide to the History and
Use of LSD. Reviewed by Ching, G. 42 (4): 513-514. DRUG TESTING
Urine testing during treatment predicts cocaine abstinence.
BUPRENORPHINE Sanchez-Hervas, E.; Romaguera, F.Z.; Gomez, F.J.S.;
Buprenorphine in the treatment of opiate dependence. Wes- Secades-Villa, R.; Garcfa-Rodriguez, O. & Yanez, E.M.
son, D. & Smith, D.E. 42 (2): 161-175. 42 (3): 347-352.
Heroin-dependent inmates’ experiences with buprenorphine
or methadone maintenance. Awgu, E.; Magura, S. & Rosen- FOOD ADDICTION
blum, A. 42 (3): 339-346. Food addiction and obesity: Evidence from bench to bedside.
Liu, Y.; von Deneen, K.M.; Kobeissy, FH. & Gold, M.S.
COCAINE 42 (2): 133-145.
Urine testing during treatment predicts cocaine abstinence.
Sanchez-Hervas, E.; Romaguera, F.Z.; Gomez, F.J.S.; ECSTASY
Secades-Villa, R.; Garcia-Rodriguez, O. & Yanez, E.M. Migration and illicit drug use among two types of male mi-
42 (3): 347-352. grants in Shanghai, China. Wong, F.Y.; He, N.; Huang, Z.J.;
Young, D.; O’Conor, C.; Ding, Y.Y.; Fu, C. & Arayasirikul,
CONTINUING CARE S. 42 (1): 1-9.
Chronic care and addictions treatment: A feasibility study Self-esteem and HIV risk practices among young adult
on the implementation of posttreatment continuing recovery Ecstasy users. Klein, H.; Elifson, K.W. & Sterk, C.E. 42
monitoring. Stanford, M.; Banerjee, K. & Garner, R. SARC (4): 447-456.
6: 295-302. Young adult Ecstasy users who forego necessary medical
Closing the gaps: The impact of inpatient detoxification and care: A fairly common occurrence with important health
continuity of care on client outcomes. Ford, L.K. & Zarate, P. implications. Elifson, K.W.; Klein, H. & Sterk, C.E. 42
SARC 6: 303-314. (1): 63-71.
DATURA STRAMONIUM HIV
Datura stramonium intake: A report on three cases. Stella, Increased drug use and STI risk with injection drug use
L.; Vitelli, M.R.; Palazzo, E.; Oliva, P.; De Novellis, V.; Capuano, among HIV-seronegative heterosexual methamphetamine
A.; Scafuro, M.A.; Berrino, L.; Rossi, F. & Maione, S. 42 (4): users. Cheng, W.S.; Garfein, R.S.; Semple, S.J.; Strathdee,
507-512. S.A.; Zians, J.K. & Patterson, T.L. 42 (1): 11-18.
Journal of Psychoactive Drugs Volume 42 (4), December 2010
Volume 42 (2010)
INJECTION DRUG USE Heroin-dependent inmates’ experiences with buprenorphine
Increased drug use and STI risk with injection drug use or methadone maintenance. Awgu, E.; Magura, S. & Rosen-
among HIV-seronegative heterosexual methamphetamine blum, A. 42 (3): 339-346.
users. Cheng, W.S.; Garfein, R.S.; Semple, S.J.; Strathdee,
S.A.; Zians, J.K. & Patterson, T.L. 42 (1): 11-18. PAIN MANAGEMENT
Managing acute and chronic pain in a substance abuse treat-
LATINAS ment program for the addicted individual early in recovery:
Correlates of heavy drinking behaviors of Latino mothers A current controversy. Markowitz, J.D.; Francis, E.M. &
and their adult daughters. Niyonsenga, T.; Rojas, P.; Dillon, Gonzales-Nolas, C. 42 (2): 193-198.
F.: Kim, S.; Ganapati, E.N. & De La Rosa, M. R. 42 (4):
457-466. PREVENTION
Indicated prevention: Bridging the gap, one person at a time.
LETTER TO THE EDITOR Harris, W.W. & Ryan, J. SARC 6: 277-285.
Letter to the editor. Krippner, S. 42 (4): 515-516. Screening, Brief Intervention, and Referral to Treatment
(SBIRT) initiatives in California: Notable trends, challenges,
MARIJUANA and recommendations. Davoudi, M. & Rawson, R.A. SARC
The influence of recency of use on fMRI response during 6: 239-248.
spatial working memory in adolescent marijuana users.
Schweinsburg, A.D.; Schweinsburg, B.C.; Medina, K.L.; Mc- PRESCRIPTION DRUGS
Queeny, T.; Brown, S.A. & Tapert, S.F. 42 (3): 401-412. Prescription drug abuse: An epidemic dilemma. DuPont,
Sex differences in the effects of marijuana on simulated R.L. 42 (2): 127-132.
driving performance. Anderson, B.M.; Rizzo, M.; Block,
R.1.; Pearlson, G.D. & O’Leary, D.S. 42 (1): 19-30. PSYCHEDELICS
Sex, drugs, and cognition: Effects of marijuana. Anderson, Evolutionary and anthropological approaches towards un-
B.M.; Rizzo, M.; Block, R.I.; Pearlson, G.D. & O’Leary, derstanding human need for psychotropic and mood altering
D.S. 42 (4): 413-424. substances. Saniotis, A. 42 (4): 477-484.
Revisiting Wasson’s Soma: Exploring the effects of prepa-
METHADONE ration on the chemistry of Amanita muscaria. Feeney, K.
Heroin-dependent inmates’ experiences with buprenorphine 42 (4): 499-506.
or methadone maintenance. Awgu, E.; Magura, S. & Rosen- Strange fires, weird smokes and psychoactive combustibles:
blum, A. 42 (3): 339-346. Entheogens and incense in ancient traditions. Dannaway,
F.R. 42 (4): 485-497.
METHAMPHETAMINE
Increased drug use and STI risk with injection drug use RECOVERY HOUSES
among HIV-seronegative heterosexual methamphetamine How do residents of recovery houses experience confronta-
users. Cheng, W.S.; Garfein, R.S.; Semple, S.J.; Strathdee, tion between entry and 12-month follow-up? Polcin, D.L.;
S.A.; Zians, J.K. & Patterson, T.L. 42 (1): 11-18. Galloway, G.P.; Bond, J.; Korcha, R. & Greenfield, T.K.
Migration and illicit drug use among two types of male mi- 42 (1): 49-62.
grants in Shanghai, China. Wong, F.Y.; He, N.; Huang, Z.J.; What did we learn from our study on sober living houses
Young, D.; O’Conor, C.; Ding, Y.Y.; Fu, C. & Arayasirikul, and where do we go from here? Polcin, D.L.; Korcha, R.;
S. 42 (1): 1-9. Bond, J. & Galloway, G. 42 (4): 425-433.
Predictors of depressive symptomatology among rural stim-
ulant users. Daniulaityte, R.; Falck, R.; Wang, J.; Carlson, SALVIA DIVINORUM
R.G.; Leukefeld, C.G. & Booth, B.M. 42 (4): 435-445. Influence of age on Salvia divinorum use: Results of an
“Tweaking and geeking, just having some fun”: An analysis Internet survey. Nyi, P.P.; Lai, E.P.; Lee, D.Y.; Biglete, S.A.;
of methamphetamine poems. Sexton, R.L.; Carlson, R.G.; Torrecer, G.I. & Anderson, I.B. 42 (3): 385-392.
Leukefeld, C.G. & Booth, B.M. 42 (3): 377-383.
SPECT IMAGING
OPIATES High resolution brain SPECT imaging in a clinical substance
Buprenorphine in the treatment of opiate dependence. Wes- abuse practice. Amen, D.G. 42 (2): 153-160.
son, D. & Smith, D.E. 42 (2): 161-175.
Differential substance abuse patterns distribute according STIMULANTS
to gender in heroin addicts. Maremmani, I.; Stefania, C.; Predictors of depressive symptomatology among rural stim-
Pacini, M.; Maremmani, A.G.I.; Carlini, M.; Golia, F.; ulant users. Daniulaityte, R.; Falck, R.; Wang, J.; Carlson,
Deltito, J. & Dell’Osso, L. 42 (1): 89-95. R.G.; Leukefeld, C.G. & Booth, B.M. 42 (4): 435-445.
Journal of Psychoactive Drugs Volume 42 (4), December 2010
Volume 42 (2010)
SUFFERING TREATMENT PERFORMANCE EVALUATON
The meaning of suffering in drug addiction and recovery Inpatient hospitalization in addiction treatment for patients
from the perspective of Existentialism, Buddhism and the with a history of suicide attempt: A case of support for
12-Step program. Chen, G. 42 (3): 363-375. treatment performance measures. Glass, J.E.; Ilgen, M.A.;
Winters, J.J.; Murray, R.L.; Perron, B.E. & Chermack, S.T.
TREATMENT 42 (3): 315-325.
Adoption of medications in substance abuse treatment: Pri- Inside the black box: Measuring addiction treatment ser-
orities and strategies of single state authorities. Rieckmann, vices and their relation to outcomes. Crévecoeur-MacPhail,
T.; Kovas, A.E. & Rutkowski, B.A. SARC 6: 227-238. D.; Ransom, L..; Myers, A.C.; Annon, J.J.; Diep, N.; Gonzales,
Adoption of motivational interviewing and motivational R..; Rawson, R.A.; Viernes, Jr., J.; Sugita, W. & Barger, J. SARC
enhancement therapy following clinical trials. Guydish, J. ; 6: 269-276.
Jessup, M. ; Tajima, B. & Manser, S.T. SARC 6: 215-226. “I’ve been NIATxed”: Participants’ experience with process
Editor’s introduction: Improving the addiction treatment system improvement. Crévecoeur-MacPhail, D.; Bellows, A.; Rut-
in California through the use of data and evidence-based practices kowski, B.A.; Ransom, L.; Myers, A.C.& Rawson, R.A.
—California Substance Abuse Research Consortium (SARC) Meet- SARC 6: 249-259.
ings, 2009. Rutkowski, B.; Rawson, R. & Freese, T. SARC Performance improvement in addiction treatment: Efforts in
6: 207-210. California. Herbeck, D.M.; Gonzales, R. & Rawson, R.A.
A field experiment in capitated payment systems and re- SARC 6: 261-268.
covery management: The Women’s Recovery Association
Pilot Study. King, B.; Kaplan, S. & Hofstedt, T. SARC 6: WOMEN
287-293. A field experiment in capitated payment systems and re-
Inpatient hospitalization in addiction treatment for patients covery management: The Women’s Recovery Association
with a history of suicide attempt: A case of support for Pilot Study. King, B.; Kaplan, S. & Hofstedt, T. SARC 6:
treatment performance measures. Glass, J.E.; Ilgen, M.A.; 287-293.
Winters, J.J.; Murray, R.L.; Perron, B.E. & Chermack, S.T. Increasing prenatal care and healthy behaviors in pregnant
42 (3): 315-325. substance users. Kropp, F.; Winhusen, T.; Lewis, D.; Hague,
Mindfulness training modifies cognitive, affective, and D. & Somoza, E. 42 (1): 73-81.
physiological mechanisms implicated in alcohol depen- Sexual assault perpetrators’ alcohol and drug use: the
dence: Results of a randomized controlled pilot trial. likelihood of concurrent violence and post-sexual assault
Garland, E.L.; Gaylord, S.A.; Boettiger, C.A. & Howard, outcomes for women victims. Busch-Armendariz, N.B.;
M.O. 42 (2): 177-192. DiNitto, D.M. ; Bell, H. & Bohman, T. 42 (3): 393-399.
A. pilot study of Seeking Safety Therapy with OEF/OIF
veterans. Norman, S.B.; Wilkins, K.C.; Tapert, S.F.; Lang,
A.J. & Najavits, L.M. 42 (1): 83-87.
Substance Abuse Research Consortium (SARC) introduc-
tion: Moving forward to improve addiction treatment in
California. Zito, R. SARC 6: 205-206.
Journal of Psychoactive Drugs Volume 42 (4), December 2010